Struggling Israeli Generics Maker Teva Finally Names New CEO

Key Speakers At 16th Nikkei Global Management Forum 2014

Health Struggling Israeli Generics Maker Teva Finally Names New CEO Seven months after Erez Vigodman stepped down, Teva Pharmaceuticals has appointed a new CEO—Kare Schultz. Schultz, who has served as CEO of Danish pharmaceutical company H. Lundbeck A/S since May

Fortune Insiders Why Martin Shkreli Won’t Be the Last Pharma Bro Martin Shkreli—famously known as the guy that jacked up the price of a lifesaving AIDS treatment by 5,000%—finally saw his day in court, albeit for a completely unrelated case involving an

Inside Teva Pharmaceuticals Headquarters

Finance Pharma Giant Teva’s Stock Is Imploding As Generic Drugs Get Cheaper Teva Pharmaceutical Industries Ltd., which has been without a permanent CEO for six months, revealed the full extent of the challenges facing its next leader by announcing more job cuts, a retreat

A sign is seen at an AstraZeneca site in Macclesfield

Health Here’s Why Shares in This Former Pfizer Target Are Tanking Shares in AstraZeneca, the U.K.-Swedish pharma company that Pfizer pfe once tried to buy for $118 billion, fell by 16% Thursday after it said the cancer drug on which it had pinned high hopes had

View of stethoscope on table in laboratory

Health Drug and Device Makers Shelled Out $8 Billion to Doctors and Hospitals Last Year One of Obamacare’s biggest transparency provisions is the Sunshine Act, which requires medical device and drug makers to disclose how much money they pony up to doctors and teaching hospitals.

Pharmaceutical Drug Roundup Inside A Pharmacy

Health Mylan Shareholders Are Being Advised to Vote Against Board Members and Executive Pay Packages Influential proxy firm ISS on Monday turned up the heat on Mylan myl , advising its institutional clients to voice their dissatisfaction with the generic drugmaker’s board of directors and

Coal Inspection And Testing At The Central Geological Laboratory

Finance Scientific Instrument Giant Thermo Fisher to Buy Patheon for About $5.2 Billion Thermo Fisher Scientific, the world’s No. 1 maker of scientific instruments, said on Monday it would buy Dutch drug ingredients maker Patheon as it looks to become a one-stop shop for contract

Health These Two Drug Companies Want to Legally Block Executions in Arkansas Arkansas has plans to execute seven death row inmates in fewer than two weeks this month. But two drug makers are trying to make sure their products play no part in the process, which has been

Abbott To Sell Generic Drug Unit To Mylan For $5.3 Billion

Finance Abbott Finally Agrees to Buy Alere After Cutting the Price to $4.5 Billion Diversified healthcare company Abbott Laboratories on Friday agreed to buy Alere for about $4.48 billion, ending a prolonged legal battle over its plan to buy the diagnostic-testing company.

The American Enterprise Institute photo of Scott Gottlieb

Health Trump Is Slashing FDA Rules. Why Isn’t Big Pharma Excited?President Donald Trump is planning to take the ax to Food and Drug Administration regulations. “[We’re] going to be streamlining the process so that, from your standpoint, when you have a drug, you

CEO Daily NewsletterSign up for CEO Daily to get must-read business news fit for the corner office—plus more.View Sample

Most Popular on FORTUNE

Here’s Why Earth, Wind & Fire Is All Over Your Twitter Feed Today

Here’s Why Earth, Wind & Fire Is All Over Your Twitter Feed Today

All of Puerto Rico’s International Airports Are Closed Due to Hurricane Maria Devastation

All of Puerto Rico’s International Airports Are Closed Due to Hurricane Maria Devastation

Japan Earthquake: Fukushima Braces for Another Possible Tsunami After 6.1-Magnitude Shock

All of Puerto Rico’s International Airports Are Closed Due to Hurricane Maria Devastation

Japan Earthquake: Photos of Fukushima’s Last Tsunami

Toya Chiba, a reporter for local newspaper Iwate Tokai Shimbun, is swept by a tsunami at Kamaishi port

Japan Earthquake: Photos of Fukushima’s Last Tsunami

Customer Service Site Map Privacy Policy Advertising Ad Choices Terms of Use Your California Privacy Rights Careers

All products and services featured are based solely on editorial selection. FORTUNE may receive compensation for some links to products and services on this website.

Quotes delayed at least 15 minutes. Market data provided by Interactive Data. ETF and Mutual Fund data provided by Morningstar, Inc. Dow Jones Terms & Conditions: http://www.djindexes.com/mdsidx/html/tandc/indexestandcs.html. S&P Index data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions